# US 2026/0076909 A1 · Solid composition and method for producing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076909 A1
- Document ID: US20260076909A1
- Status: Published application
- Kind: A1
- Application number: 19/109,989
- Filed: 2023-10-12
- Published: 2026-03-19
- Earliest claimed: 2022-10-21
- Assignees: DKS Co. Ltd.
- Applicants: DKS Co. Ltd.
- Inventors: Toru IWAKI; Yuri KADO; Kohei MATSUMOTO; YUKO MORITA; Kaito ONISHI; Mai WATANABE; Kana TERAGAMI
- Web page: https://patentgrep.com/patent/US20260076909A1

## CPC

- A61K 9/145: {with organic compounds}
- A23L 29/00: Foods or foodstuffs containing additives (containing additives for modifying the nutritive qualities A23L33/10; containing substantially indigestive additives, e.g. dietary fibres, A23L33/21; containing additives for preservation A23B); Preparation or treatment thereof
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/146: {with organic macromolecular compounds}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 45/00: Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The solubility of cannabinoid in water is improved. A solid composition according to an embodiment contains an amorphous cannabinoid, a sucrose fatty acid ester having a monoester ratio of 85 mass % or more, and a water-soluble polymer. The solid composition can be prepared by, for example, dissolving a cannabinoid, a sucrose fatty acid ester having a monoester ratio of 85 mass % or more, and a water-soluble polymer in a solvent, and removing the solvent from the resultant solution.

## Claims

### Claim 1

A solid composition comprising:
an amorphous cannabinoid;
a sucrose fatty acid ester having a monoester ratio of 85 mass % or more; and
a water-soluble polymer.

### Claim 2 (depends on 1)

The solid composition according to claim 1, wherein a mass ratio of the sucrose fatty acid ester to the cannabinoid is 0.2 to 30.

### Claim 3 (depends on 1)

The solid composition according to claim 1, wherein a mass ratio of the water-soluble polymer to the cannabinoid is 0.2 to 30.

### Claim 4 (depends on 1)

The solid composition according to claim 1, wherein a mass ratio of the water-soluble polymer to the sucrose fatty acid ester is 0.1 to 10.

### Claim 5 (depends on 1)

The solid composition according to claim 1, wherein the sucrose fatty acid ester includes a fatty acid having 12 to 22 carbon atoms as a constituent fatty acid.

### Claim 6 (depends on 1)

The solid composition according to claim 1, wherein the water-soluble polymer includes at least one selected from the group consisting of homopolymers of N-vinyllactams, copolymers of N-vinyllactams, cellulose ethers, cellulose esters, polyalkylene glycols, and polyalkylene oxides.

### Claim 7 (depends on 1)

The solid composition according to claim 1, wherein the cannabinoid includes at least one selected from the group consisting of cannabidiol, cannabigerol, tetrahydrocannabinol, and cannabinol.

### Claim 8 (depends on 1)

An oral composition comprising the solid composition according to claim 1.

### Claim 9

A method for producing a solid composition, the method comprising:
dissolving a cannabinoid, a sucrose fatty acid ester having a monoester ratio of 85 mass % or more, and a water-soluble polymer in a solvent to obtain a solution; and
removing the solvent from the solution.
